Clinical Trial

Ampicillin and Ceftriaxone for the Treatment of Enterococcus Faecalis Infective Endocarditis.

Study acronym: DOBLEI
Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
Phase IV, open-label, randomized and multicenter clinical trial to prove that patients with Enterococcus faecalis infective endocarditis treated with an antibiotic treatment as a continuous infusion is non-inferior to the standard treatment, usually administered in hospitalized patients.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-05-16; most recent amendment 2025-07-24.
Status change: Not Yet Recruiting → Recruiting 2025-07-24
Trial Details
NCT Number NCT06423898
Lead Sponsor Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Collaborators: Spanish Clinical Research Network - SCReN
Conditions Endocarditis, Infective
Enrollment 284 participants
Start Date 2024-10-09
Primary Completion 2027-07-31 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-07-25